BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND PWWP2A, Q8IYR3_HUMAN, Q96N64, MST101, MGC132770, KIAA1935, ENSG00000170234, 114825 AND Prognosis
1097 results:

  • 1. Upregulation of circ_0076684 in osteosarcoma facilitates malignant processes by mediating miRNAs/CUX1.
    Cai P; Fu X; Li X; Zhao W
    J Orthop Surg Res; 2024 Apr; 19(1):260. PubMed ID: 38659042
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Fibroblast Growth Factor 23 is a Potential Prognostic Biomarker in Uterine Sarcoma.
    Yang L; Cai Y; Wang Y; Huang Y; Zhang C; Ma H; Zhou JG
    Technol Cancer Res Treat; 2024; 23():15330338241245924. PubMed ID: 38613349
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Transient Receptor Potential Ankyrin 1 Ion Channel Is Expressed in Osteosarcoma and Its Activation Reduces Viability.
    Hudhud L; Rozmer K; Kecskés A; Pohóczky K; Bencze N; Buzás K; Szőke É; Helyes Z
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612571
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Vitexicarpin Induces Apoptosis and Inhibits Metastatic Properties via the AKT-PRAS40 Pathway in Human Osteosarcoma.
    Yun HM; Kwon HS; Lee JY; Park KR
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612399
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Establishment of Patient-Derived Xenograft Mouse Model with Human Osteosarcoma Tissues.
    Sun X; Chang J; Zhou C; Zhao P; Guo S; Tong J; Wang Y; Yang Y
    J Vis Exp; 2024 Mar; (205):. PubMed ID: 38587398
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Targeting RCC1 to block the human soft-tissue sarcoma by disrupting nucleo-cytoplasmic trafficking of Skp2.
    Zhuang M; Li F; Liang H; Su Y; Cheng L; Lin B; Zhou J; Deng R; Chen L; Lyu P; Lu Z
    Cell Death Dis; 2024 Apr; 15(4):241. PubMed ID: 38561375
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The Effects of Fucoidan Derived from
    Gupta D; Martinez DC; Puertas-Mejía MA; Hearnden VL; Reilly GC
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396762
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Integrated transcriptomic analysis systematically reveals the heterogeneity and molecular characterization of cancer-associated fibroblasts in osteosarcoma.
    Liu Y; Han X; Han Y; Bi J; Wu Y; Xiang D; Zhang Y; Bi W; Xu M; Li J
    Gene; 2024 May; 907():148286. PubMed ID: 38367852
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Prognostic impact of HER2 biomarker levels in trastuzumab-treated early HER2-positive breast cancer.
    Rönnlund C; Sifakis EG; Schagerholm C; Yang Q; Karlsson E; Chen X; Foukakis T; Weidler J; Bates M; Fredriksson I; Robertson S; Hartman J
    Breast Cancer Res; 2024 Feb; 26(1):24. PubMed ID: 38321542
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Development of a prognostic Neutrophil Extracellular Traps related lncRNA signature for soft tissue sarcoma using machine learning.
    Liu B; He S; Li C; Li Z; Feng C; Wang H; Tu C; Li Z
    Front Immunol; 2023; 14():1321616. PubMed ID: 38264665
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Nε-(1-Carboxymethyl)-L-lysine/RAGE Signaling Drives Metastasis and Cancer Stemness through ERK/NFκB axis in Osteosarcoma.
    Chang TY; Lan KC; Wu CH; Sheu ML; Yang RS; Liu SH
    Int J Biol Sci; 2024; 20(3):880-896. PubMed ID: 38250151
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A novel method for detection of pancreatic Ductal Adenocarcinoma using explainable machine learning.
    Aslam M; Rajbdad F; Azmat S; Li Z; Boudreaux JP; Thiagarajan R; Yao S; Xu J
    Comput Methods Programs Biomed; 2024 Mar; 245():108019. PubMed ID: 38237450
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A novel aging-associated lncRNA signature for predicting prognosis in osteosarcoma.
    He Y; Huang X; Ma Y; Yang G; Cui Y; Lv X; Zhao R; Jin H; Tong Y; Zhang X; Li J; Peng M
    Sci Rep; 2024 Jan; 14(1):1386. PubMed ID: 38228673
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. β-hCG secreting uterine PEComa.
    Murphy P; Machlab K; Almohsen S; Fratesi J; Watson G
    BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38216169
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Establishment and Characterization of Cell Lines from Canine Metastatic Osteosarcoma.
    Yang YT; Engleberg AI; Yuzbasiyan-Gurkan V
    Cells; 2023 Dec; 13(1):. PubMed ID: 38201229
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Updates in Osteosarcoma.
    Bryan JN
    Vet Clin North Am Small Anim Pract; 2024 May; 54(3):523-539. PubMed ID: 38158305
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Current understanding of comparative pathology and prospective research approaches for canine hemangiosarcoma.
    Suzuki T; Henshaw MJ; Yanagi T; Aoshima K
    Res Vet Sci; 2024 Feb; 167():105120. PubMed ID: 38150941
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Development and validation of neutrophil extracellular traps-derived signature to predict the prognosis for osteosarcoma patients.
    Lin Y; Tang H; Teng H; Feng W; Li F; Liu S; Liu Y; Wei Q
    Int Immunopharmacol; 2024 Jan; 127():111364. PubMed ID: 38101221
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Identification of ACBD3 as a new molecular biomarker in pan-cancers through bioinformatic analysis: a preclinical study.
    Ma X; Huang S; Shi H; Luo R; Luo B; Tan Z; Shi L; Zhang W; Yang W; Zhong X; Lü M; Chen X; Tang X
    Eur J Med Res; 2023 Dec; 28(1):590. PubMed ID: 38098097
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Exploring the role of lactylation-related genes in osteosarcoma: A deep dive into prognostic significance and therapeutic potential.
    Sun J; Li Y; Chen R; Xie Y; Wei J; Li B
    Environ Toxicol; 2024 Feb; 39(2):1001-1017. PubMed ID: 38009602
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 55.